NCT05054725 2026-01-06Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard TherapiesRevolution Medicines, Inc.Phase 2 Completed47 enrolled 17 charts
NCT03085069 2023-02-16A Study to Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLCJiangsu HengRui Medicine Co., Ltd.Phase 2 Unknown146 enrolled
NCT02941601 2019-09-27A Study of Gemcitabine-Carboplatin Plus Necitumumab (LY3012211) in Chemotherapy-Naïve Participants With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)Eli Lilly and CompanyPhase 2 Withdrawn